M

McKesson

Supplies medicines and technology to healthcare teams

Lead Program Manager - Oncology and Multi Specialty Technology Strategy

Full-Time
$122.1k - $162.8k+ Annual bonus + Long-term incentives
Expert
Bachelor's
Mississauga, ON, Canada
HybridTwo days per week in the office.
Project & Program ManagementProgram Management

About the job

Requirements
  • A bachelor's degree in business administration, information technology, computer science, healthcare administration, healthcare informatics, engineering, or a related field, or equivalent experience.
  • Typically 10+ years of progressive experience in project or program management, technology governance, risk and compliance, portfolio delivery, business operations, or a related discipline.
  • Proven experience leading large, complex, cross-functional programs or multiple related initiatives with critical business value, competing priorities, and substantial consequences of success or failure.
  • Demonstrated success managing program roadmaps, scope, milestones, dependencies, risks, issues, resources, governance forums, and executive reporting with a high degree of autonomy.
  • Experience establishing or maturing governance frameworks, delivery standards, operating models, controls, performance measures, and continuous improvement practices.
  • Demonstrated ability to partner with senior business and technology stakeholders, influence decisions without direct authority, resolve conflict, and drive accountability across organizational boundaries.
  • Experience using data, dashboards, automation, predictive insights, or scenario analysis to improve program visibility, prioritization, risk management, and decision quality.
  • Advanced program management: translate strategic objectives into roadmaps, integrated plans, measurable outcomes, governance structures, and disciplined execution across multiple related initiatives.
  • Program risk and dependency management: anticipate, consolidate, prioritize, and mitigate complex risks, issues, constraints, and cross-functional dependencies.
  • Stakeholder leadership and influence: build strategic relationships, adapt communication to the audience, negotiate effectively, and create alignment among business, technology, legal, compliance, security, privacy, data, and architecture stakeholders.
  • Business and customer orientation: connect governance decisions and delivery priorities to business outcomes, stakeholder value, enterprise objectives, and responsible risk management.
  • Executive communication: prepare concise, decision-ready briefings, dashboards, recommendations, and escalations for senior leaders and governance bodies.
  • Planning and prioritization: self-direct complex work, establish clarity of roles and decision rights, manage competing priorities, and maintain predictable delivery against commitments.
  • Analytical problem solving: synthesize information from multiple sources, identify root causes, evaluate options, and implement practical solutions in ambiguous or evolving situations.
  • Change leadership and continuous improvement: challenge stakeholder mindsets constructively, drive adoption of new practices, embed feedback loops, and improve program maturity and scalability.
  • Digital fluency: advanced proficiency with Smartsheet, Power BI, Excel, or comparable portfolio, workflow, reporting, and analytics platforms, including building and troubleshooting dashboards and automated reporting.
  • Responsible handling of information: exercise sound judgment, discretion, and rigor when working with confidential, regulated, or risk-sensitive information.
Responsibilities
  • Break down Responsible AI program objectives into measurable business and technology outcomes, and maintain a program roadmap that translates governance requirements into executable plans, milestones, deliverables, and success measures.
  • Lead the end-to-end AI Use Case governance lifecycle across intake, triage, RAIB Operations quality review, RAIB and EAIC review, final decision, control implementation, and ongoing monitoring.
  • Partner with program sponsors and senior stakeholders to align governance priorities, secure support, resolve high-visibility issues, and ensure the program continues to deliver enterprise value.
  • Establish and maintain the program governance structure, operating cadence, decision rights, escalation paths, service-level objectives, and delivery standards consistent with McKesson's Responsible AI Program, Responsible AI Policy, and RAIB Charter.
  • Identify, consolidate, and manage program-level risks, issues, interdependencies, and resource constraints across governance activities; develop mitigation plans, assign accountable owners, and escalate significant risks with recommended actions.
  • Lead scope, priority, and risk trade-off discussions with stakeholders, driving consensus while preserving policy, control, documentation, and audit requirements.
  • Ensure governance records, risk assessments, approvals, conditions, controls, and notifications are complete, accurate, timely, and audit-ready.
  • Lead preparation and execution of RAIB sessions and, when required, EAIC secondary reviews in partnership with the RAIB Operations and Governance Lead and Senior Product Portfolio Manager.
  • Ensure review materials enable informed decisions and that every decision, condition, action, owner, and due date is documented accurately in Smartsheet and communicated within the required response window.
  • Serve as the first escalation path for at-risk submissions, unresolved information gaps, missed commitments, or stakeholder conflicts that could affect governance quality, cycle time, or program outcomes.
  • Act as a trusted program advisor to business and technology stakeholders, translating Responsible AI requirements into clear actions, decision points, and ownership expectations.
  • Build and maintain strategic cross-functional relationships, establish effective feedback loops, and lead regular interactions with sponsors and stakeholders to inform, alert, negotiate, and drive timely resolution.
  • Influence adoption of Responsible AI governance practices without direct authority through clear communication, consultation, education, and disciplined follow-through.
  • Define, maintain, and report program key performance indicators and service-level measures, including submission volume, risk-tier trends, cycle time, backlog health, control status, decision timeliness, and stakeholder responsiveness.
  • Develop executive-ready dashboards, scorecards, forecasts, and portfolio health reporting that convert governance data into actionable insights, risks, decisions, and improvement priorities.
  • Work with sponsors to assess program effectiveness, stakeholder satisfaction, and realized business value; recommend adjustments that improve quality, throughput, transparency, and scalability.
  • Use automation, analytics, and AI-enabled insights where appropriate to improve forecasting, identify emerging risks, strengthen prioritization, and reduce manual reporting effort.
  • Lead continuous improvement of intake questions, control inventories, risk-tiering methods, review workflows, decision documentation, and monitoring practices.
  • Facilitate lessons learned and retrospective reviews, convert findings into owned actions, and track implementation through measurable improvement.
  • Establish and promote Responsible AI governance standards, reusable tools, and best practices; provide guidance and mentorship to team members and partners supporting the program.
  • Champion a digital-first governance model that embeds analytics, automation, feedback loops, and clear accountability into program operations.
Desired Qualifications
  • Healthcare, health technology, regulated-industry, Responsible AI, AI governance, privacy, security, compliance, or technology risk experience is strongly preferred.

About the company

McKesson distributes medicines and medical supplies to pharmacies, hospitals and other care providers, alongside services that connect drug manufacturers with patients. Its specialty businesses support community cancer care and clinical research, extending its work beyond moving products through warehouses. The company buys drugs and supplies from manufacturers for resale, while its software helps pharmacies manage inventory and healthcare teams secure insurance approval for prescriptions. It also sells practice management and patient support services to clinicians and drugmakers. McKesson traces its business roots to 1833 and is headquartered in Irving, Texas.

Company Size

10,001+

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Get referred to McKesson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Reinvestment has cash behind it: McKesson reported $6.2 billion operating cash flow for fiscal 2026 in May 2026.
  • Specialty expansion drives growth: McKesson reported 31% higher fiscal 2026 Oncology and Multispecialty sales in May 2026.
  • Technical candidates have openings: McKesson lists 154 information technology jobs on its career site in October 2026.

What critics are saying

  • One customer holds bargaining power: CVS generated 24% of McKesson's fiscal 2026 revenue, reported in May 2026.
  • Technology jobs face cuts: McKesson approved prescription technology headcount reductions during January through March 2026.
  • Medical supply careers face separation: McKesson outlined a planned Medical-Surgical IPO alongside Apollo's investment agreement in April 2026.

What makes McKesson unique

  • McKesson backs independent ownership: its Health Mart franchise supports pharmacies that remain independently owned and operated.
  • Generic purchasing has a retail partner: McKesson and Walmart jointly source medicines through ClarusONE.
  • McKesson reaches prescribing workflows: CoverMyMeds processes insurance approval requests free for clinicians across all plans and medications.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
TradingView
Oct 6th, 2026
CD&R and McKesson to acquire Option Care Health.

CD&R and McKesson to acquire Option Care Health. WASHINGTON (dpa-AFX) - CD&R, McKesson (MCK) and Option Care Health (OPCH) have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health for $32.05 per share, reflecting a total enterprise value of approximately $5.8 billion. Upon completion, Option Care Health will become a privately held company. CD&R will hold a majority interest of approximately 51% in Option Care Health and McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. The deal establishes a framework for McKesson's future acquisition of CD&R's interest in Option Care Health, subject to specified conditions and regulatory approvals. Option Care Health is an independent provider of home and alternate site infusion services. In pre-market trading on NasdaqGS, Option Care shares are up 20.50 percent to $28.16. For More Such Health News, visit rttnews.com. Copyright(c) 2026 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX Read the full article

JH Consulting Online
Sep 22nd, 2026
Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer.

Cara McDonough joins McKesson Medical-Surgical as Chief Product Strategy & Supplier Partnerships Officer. September 22, 2026- McKesson Medical-Surgical has announced that Cara McDonough has joined the organization as Chief Product Strategy & Supplier Partnerships Officer, effective September 14, 2026. In this role, Cara will lead McKesson Medical-Surgical's Product Strategy and Supplier Partnerships teams, guiding supplier relationship strategy and portfolio development across the company's Private Label, Pharmaceutical, Consumer Markets, and Laboratory businesses as a member of the Executive Committee. Cara brings 20 years of experience leading and growing product-focused organizations. Throughout her career, she has held senior leadership positions with nationally recognized companies, driving merchandising, private label, product strategy, and commercial growth across multiple channels, including B2B, e-commerce, and retail. Her experience building differentiated product portfolios, strengthening supplier relationships, and delivering profitable growth aligns closely with the organization's long-term strategy. As McKesson Medical-Surgical continues evolving its business, Cara's leadership will help further strengthen supplier partnerships and support the organization's commitment to delivering innovative solutions and value to customers.

McKesson Corporation
Sep 21st, 2026
McKesson Signs Agreement to Acquire Precision Medicine Group, LLC

McKesson Corporation (NYSE: MCK) announced today that it signed a definitive agreement to acquire Precision Medicine Group, LLC (“Precision Medicine Group”), a global provider of clinical research and biopharma commercialization services.

Compass Oncology
Sep 15th, 2026
Compass Oncology earns first Green Building certification for a medical facility.

Compass Oncology earns first Green Building certification for a medical facility. Sep 15, 2026 What was once a vacant Toys "R" Us and BuyBuy Baby is now setting a new standard for sustainable healthcare At McKesson, Compass Oncology understand that the spaces where Compass Oncology work, distribute and care have a profound impact on its planet and people. In FY24, Compass Oncology developed McKesson's Green Building Standards (GBS) - an internal sustainability framework that provides guidance for eligible building design, construction and operations projects. Across its offices, distribution centers and eligible healthcare buildings, GBS is intended to support environmental performance, operational efficiency and employee well-being. Since inception, Compass Oncology has assessed 52 buildings and achieved 17 GBS certifications, including three Platinum, two Gold, 11 Silver and one Compliant. Compass Oncology, a practice in the US Oncology Network, recently became the first medical building to earn McKesson GBS certification at its East Cancer Center in Happy Valley, Oregon. The achievement is particularly notable because the facility was transformed from a former retail store into a modern healthcare environment developing its East Cancer Center, Compass Oncology partnered with the McKesson Real Estate team to repurpose the existing structure to GBS and create a space designed to support patients, caregivers and employees. Compass Oncology's East Cancer Center earned GBS Silver credit through a range of sustainability and wellness-focused features: * Energy and performance: High-efficiency HVAC systems and STAR appliances * Air Quality & Health: Enhanced air filtration supporting an indoor environment * Water Stewardship: Water-efficient plumbing fixtures that conserve resources * Materials & Carbon Impact: Adaptive reuse strategies that embodied carbon * Wellness & Experience: Bike racks and a thoughtfully designed garden that support employee well-being "At McKesson, we believe advancing health outcomes includes a commitment to creating healthier environments for the people and communities we serve, said Nimesh Jhaveri, R.Ph., Executive Vice President and Chief Impact Officer at McKesson. "Compass Oncology's achievement is an important milestone, not only as the first medical building to earn Green Building Standards certification, but also as a powerful example of how sustainability can be integrated into healthcare settings." Congratulations to Compass Oncology and the McKesson Real Estate team on this pioneering accomplishment!

WTWH Media
Sep 11th, 2026
Modivcare names new CEO of personal care services; LifeCare appoints new COO.

Modivcare names new CEO of personal care services; LifeCare appoints new COO. Modivcare names new CEO of personal care services, chief corporate affairs officer. Modivcare named Marshalina "Marsha" Ramos CEO of the personal care services (PCS) business on Sept. 8, where she will oversee the company's PCS portfolio. Prior to joining Modivcare, Ramos served as founder and CEO of home care and hospice advisory firm Visionary Group. She also acted as president and chief operating officer of home-based care provider Premier Home Health Care and held numerous senior roles at home care provider VNS Health. "[Ramos] has built and stabilized multi-state home care operations, navigated complex regulatory and managed care environments and earned the loyalty of the teams she has led," Modivcare Board of Managers Chair Leslie Norwalk said in a statement. "With Marsha's addition to the Modivcare team, each of our businesses is now led by a seasoned executive with deep industry expertise and a strong understanding of the markets they serve." The company tapped Matt Williams to serve as chief corporate affairs officer effective Sept. 1. He will oversee Modivcare's corporate reputation and communications, regulatory affairs and public policy and focus on bolstering the company's stakeholder engagement and advocacy. Williams previously served as vice president of government affairs at McKesson, a medical supplies and pharmaceutical healthcare company, and major pharmaceutical manufacturer AbbVie. "I'm honored to join Modivcare at an important time for the company," Williams said in a statement. "I look forward to working alongside teams across the organization to strengthen our reputation, deepen relationships with policymakers, clients and other stakeholders, and advance our mission." Denver-based Modivcare provides nonemergency medical transportation, personal care, remote monitoring and integrative supportive care across 35 states. LifeCare Home Health & Hospice Family appoints new chief operating officer. Dr. Nasser Khan joined LifeCare Home Health & Hospice Family as president and COO, where he will manage operations across the company's portfolio and scale growth and integrations. Khan previously served as COO of behavioral health company Acadia Healthcare, in addition to roles at specialty pharmacy solutions provider Shields Health Solutions, kidney dialysis provider DaVita Kidney Care, preventive diagnostics clinic Biograph and global management consulting company McKinsey & Company. "Dr. Khan brings a rare combination of clinical insight, operational experience and demonstrated leadership at scale," LifeCare Home Health & Hospice Family CEO Dean Alverson said in a statement. "As LifeCare continues to grow, his experience developing teams, strengthening operations and bringing organizations together will be invaluable." Irving, Texas-based LifeCare Home Health & Hospice Family offers home health, hospice and in-home care throughout 39 locations in Texas, Florida, Georgia, Nevada and Arizona. BrightSpring taps Alliance VP as vice president of federal government relations. Hillary Loeffler joined BrightSpring Health Services (Nasdaq: BTSG) as vice president of federal government relations in August 2026, according to her LinkedIn profile. Before joining BrightSpring, Loeffler served as vice president of policy and regulatory affairs for the National Alliance for Care at Home and held various roles at the Centers for Medicare & Medicaid Services (CMS) for over 13 years. Louisville, Kentucky-based BrightSpring Health Services provides home health, personal care, infusions and specialty pharmaceuticals, hospice and other services throughout all 50 states. Senior1Care names cate Palace president of Northeast region. Cate Palace will serve as the president of the Northeast region for Senior1Care, where she is charged with handling growth and operations in three Indiana cities. Palace has over 20 years of experience including leading home care, skilled nursing, assisted rehabilitation and other agencies providing services for older adults. "Palace understands senior care from both a clinical and operational perspective and recognizes the role relationships play in earning the trust of families, healthcare partners and the communities we serve," Senior1Care CEO Kyle Bossung said in a statement. "I'm grateful she chose to bring that perspective to Senior1Care and look forward to having her as part of our leadership team." Senior1Care, based in Mishawaka, Indiana, provides personal care and companionship services across the Angola, Elkhart, Fort Wayne, Indianapolis, South Bend and Warsaw regions of Indiana. Porter appoints Jeff Fox as chief growth officer. Porter named Jeff Fox chief growth officer. He is charged with leading the company's growth strategy, relationships with health plans, strategic partnerships and technology expansion. Baltimore-based Porter is a healthcare IT and services platform that offers care coordination and in-home care assessments for families, individuals, payers and at-risk providers. Fox previously led Atrio Health Plans as CEO, where he aided the firm's expansion into new markets, and oversaw Gorman Health Group for 17 years as president and CEO. "Jeff knows this business and the people it serves," Porter Founder, CEO and Chairman John Criswell said in a statement. "He understands how health plans work, the pressures they face, and what is at stake for the people who depend on them. That experience will help Porter grow with purpose and deliver at a greater scale." Companies featured in this article: MK Manoylov is a Senior Reporter at Home Health Care News. Their work has appeared in publications including WebMD, Business Insider and LiveScience, in addition to governmental reports from the U.S. Department of the Treasury. MK earned a master's degree in journalism in the Science, Health and Environmental Reporting (SHERP) from New York University.